Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients

Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients

Literature search has shows that both ferric carboxymaltose and iron sucrose complex are equally effective. Unfortunately, local data addressing this issue is scarce. To get further local data, the current study was planned with the objective to compare the mean change in hemoglobin with ferric carboxymaltose and IV iron sources in anemic antenatal patients in our local population.

It was hypothesized that there was a difference in mean change in hemoglobin with ferric carboxymaltose as compared to IV iron sources in anemic antenatal patients. The findings of the study would be a valuable addition to the existing stats, and if the hypothesis stands correct, a large number of women of reproductive age would benefit from effective iron replacement therapy, with a comparatively low incidence of side effects.

Inclusion Criteria:

• Pregnant women
• Aged 18 to 40 years
• Presented with anemia
• Any parity
• Gestational age < 12 weeks on LMP

Exclusion Criteria:

• Females with a history of hypertension
• Type II diabetes mellitus
• Gestational diabetes mellitus
• Ischemic heart disease
• Endocrine disorder
• Hematological disorders (hemophilia, leukemia, lymphoma, or myeloma)
• History of taking iron-lowering drugs